Search research articles
Contact Us
Filters
Showing results (141-150 of 152) with videos related to
Page
of 16
Sort By:
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
August 16, 2021
BPIFB4 Circulating Levels and Its Prognostic Relevance in COVID-19
Elena Ciaglia, Valentina Lopardo, Francesco Montella, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
July 18, 2024
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial
Raffaele Piccolo, Fiorenzo Simonetti, Marisa Avvedimento, et al.
Cardiovascular Research
|
December 21, 2007
Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart
Dario Leosco, Giuseppe Rengo, Guido Iaccarino, et al.
Frontiers in Pharmacology
|
April 23, 2026
Sex differences in levodopa pharmacokinetics in early Parkinson's disease: implications on levodopa-related complications
Valeria Conti, Emanuela De Bellis, Graziamaria Corbi, et al.
Frontiers in Medicine
|
June 17, 2022
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson's Disease
Valeria Conti, Viviana Izzo, Maria Claudia Russillo, et al.
Journal of Thrombosis and Thrombolysis
|
November 16, 2025
Sex differences among elderly ACS patients undergoing percutaneous coronary intervention receiving Ticagrelor 60 mg vs. 90 mg
Raffaele Piccolo, Angelo Laino, Antonio Pio Vitale, et al.
Cardiovascular Drugs and Therapy
|
January 20, 2022
Platelet Inhibition with Ticagrelor 60 mg Versus 90 mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial
Raffaele Piccolo, Marisa Avvedimento, Mario Enrico Canonico, et al.
Frontiers in Immunology
|
June 24, 2021
PD-L1 Dysregulation in COVID-19 Patients
Francesco Sabbatino, Valeria Conti, Gianluigi Franci, et al.
The Pharmacogenomics Journal
|
December 6, 2019
Prospective validation of the International Warfarin Pharmacogenetics Consortium algorithm in high-risk elderly people (VIALE study)
Amelia Filippelli, Simona Signoriello, Ciro Bancone, et al.
Molecular Cancer
|
March 26, 2024
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC
Giovanna Polcaro, Luigi Liguori, Valentina Manzo, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 152) with videos related to
Sort By:
Page
of 16
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
August 16, 2021
BPIFB4 Circulating Levels and Its Prognostic Relevance in COVID-19
Elena Ciaglia, Valentina Lopardo, Francesco Montella, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
July 18, 2024
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial
Raffaele Piccolo, Fiorenzo Simonetti, Marisa Avvedimento, et al.
Cardiovascular Research
|
December 21, 2007
Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart
Dario Leosco, Giuseppe Rengo, Guido Iaccarino, et al.
Frontiers in Pharmacology
|
April 23, 2026
Sex differences in levodopa pharmacokinetics in early Parkinson's disease: implications on levodopa-related complications
Valeria Conti, Emanuela De Bellis, Graziamaria Corbi, et al.
Frontiers in Medicine
|
June 17, 2022
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson's Disease
Valeria Conti, Viviana Izzo, Maria Claudia Russillo, et al.
Journal of Thrombosis and Thrombolysis
|
November 16, 2025
Sex differences among elderly ACS patients undergoing percutaneous coronary intervention receiving Ticagrelor 60 mg vs. 90 mg
Raffaele Piccolo, Angelo Laino, Antonio Pio Vitale, et al.
Cardiovascular Drugs and Therapy
|
January 20, 2022
Platelet Inhibition with Ticagrelor 60 mg Versus 90 mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial
Raffaele Piccolo, Marisa Avvedimento, Mario Enrico Canonico, et al.
Frontiers in Immunology
|
June 24, 2021
PD-L1 Dysregulation in COVID-19 Patients
Francesco Sabbatino, Valeria Conti, Gianluigi Franci, et al.
The Pharmacogenomics Journal
|
December 6, 2019
Prospective validation of the International Warfarin Pharmacogenetics Consortium algorithm in high-risk elderly people (VIALE study)
Amelia Filippelli, Simona Signoriello, Ciro Bancone, et al.
Molecular Cancer
|
March 26, 2024
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC
Giovanna Polcaro, Luigi Liguori, Valentina Manzo, et al.
Page
of 16